These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2091076

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Could conditional release of new drugs provide the information required to study drug effectiveness? - A discussion paper.
    Rawson NS, West R, Appel WC.
    Can J Clin Pharmacol; 2000; 7(4):185-90. PubMed ID: 11118964
    [Abstract] [Full Text] [Related]

  • 23. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK, Swartz L.
    Arch Intern Med; 2005 Jun 27; 165(12):1363-9. PubMed ID: 15983284
    [Abstract] [Full Text] [Related]

  • 24. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ, Spielmann H.
    Arch Toxicol; 2005 Nov 27; 79(11):615-26. PubMed ID: 15940470
    [Abstract] [Full Text] [Related]

  • 25. [Methodological characteristics of the preclinical study of the safety of drug preparations for children].
    Mal'tseva LF, Muratova GP, Motovilova VG, Sirinova NA.
    Farmakol Toksikol; 1988 Nov 27; 51(4):96-100. PubMed ID: 3191987
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Regulatory decisions and consumers.
    Rawlins MD.
    Med Toxicol; 1986 Nov 27; 1 Suppl 1():128-9. PubMed ID: 3821428
    [Abstract] [Full Text] [Related]

  • 31. Research methods in drug surveillance.
    Engel RR, Grohmann R, Rüther E, Hippius H.
    Pharmacopsychiatry; 2004 Mar 27; 37 Suppl 1():S12-5. PubMed ID: 15052510
    [Abstract] [Full Text] [Related]

  • 32. Post marketing surveillance. Traps for the unwary.
    Marley J, Mant A.
    Aust Fam Physician; 1993 Jun 27; 22(6):1009-11, 1013. PubMed ID: 8338446
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [The current requirements for the preclinical study of the safety of new drugs].
    Arzamastsev EV, Liubimov BI.
    Eksp Klin Farmakol; 1995 Jun 27; 58(3):7-12. PubMed ID: 7663306
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Discussion on methods of sample size estimation in conducting clinical reevaluation of postmarketing Chinese medicine].
    Tian F, Fu Y, Xie Y.
    Zhongguo Zhong Yao Za Zhi; 2011 Apr 27; 36(8):1097-102. PubMed ID: 21809593
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.